MENU

CVM

Stock ticker: ASE

PRICE

CHANGE

CAPITALIZATION

Cel-Sci (CVM) Ownership - Who owns Cel-Sci?

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

8229 Boone Boulevard

Phone

+1 703 506-9460

Employees

57

Web

https://www.cel-sci.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

15.65M

P/E Ratio

N/A

Total Cash

1.89M

Projected Growth

N/A

Total Debt

8.51M

Revenue

N/A

Risk (Beta)

0.80

Dividend Yield

N/A

Total Cash/Share

0.13

Total Debt/Equity

15.30

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

CVM

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CVM

A.I. Advisor

published General Information

General Information

a provider of immunotherapy products for the treatment of cancer and infectious diseases

Industry Biotechnology

Profile

Details

Industry

Biotechnology

Address

8229 Boone Boulevard

Phone

+1 703 506-9460

Employees

57

Web

https://www.cel-sci.com